Tofadoz 20mg Gel

Introduction

Tofadoz is a prescription medication that contains the active ingredient Tofacitinib. It is available in the form of a topical gel and is primarily used to treat certain skin conditions.

Uses

Tofadoz is prescribed to patients with moderate to severe plaque psoriasis, a chronic skin condition characterized by thick, red, and scaly patches on the skin. It is also used to treat adults with moderate to severe atopic dermatitis, a type of eczema that causes itchy and inflamed skin.

Dosage and Administration

The recommended dosage of Tofadoz is to apply a thin layer to the affected areas of the skin twice daily. Wash your hands before and after applying the gel. Avoid applying the gel to broken or damaged skin, as well as to the eyes, mouth, or other mucous membranes.

Mechanism of Action

Tofacitinib, the active ingredient in Tofadoz, is a Janus kinase inhibitor. It works by reducing inflammation in the skin and suppressing the immune response that contributes to the symptoms of psoriasis and atopic dermatitis. By targeting specific proteins involved in the inflammatory process, Tofacitinib helps to alleviate the redness, scaling, and itching associated with these conditions.

Side Effects

Common side effects may include mild skin irritation, such as redness, itching, or burning at the application site. These side effects are usually temporary and should resolve on their own.

However, if you experience any severe or persistent side effects, such as severe allergic reactions, skin infections, or changes in vision, seek medical attention immediately.

Drug Interactions

inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs, vitamins, and herbal supplements. Some medications may interact with Tofadoz and affect its effectiveness or increase the risk of side effects.

It is particularly important to avoid using other topical medications or products on the same area of skin without consulting your healthcare provider.

Precautions

Before using Tofadoz, inform your healthcare provider about any known allergies or sensitivities to medications. You should also let them know about any pre-existing medical conditions, such as infections or skin diseases.

Tofadoz should not be used in patients who are pregnant or planning to become pregnant, as it may harm the developing fetus. It is also not recommended for use in breastfeeding women, as the potential risks to the nursing infant are not yet known.

Storage

Tofadoz should be stored at room temperature, away from direct sunlight and moisture. Keep the gel out of reach of children and pets. Do not freeze the gel.

Patient Tips

• Follow your healthcare provider’s instructions on how to apply Tofadoz correctly.
• Avoid using more than the recommended amount of gel, as it will not improve the effectiveness of the medication and may increase the risk of side effects.
• If you accidentally get the gel in your eyes, rinse them thoroughly with water.
• continue using Tofadoz as prescribed, even if you start to see improvement in your skin condition. Stopping the medication prematurely may cause your symptoms to return.
• If you have any questions or concerns about Tofadoz, don’t hesitate to reach out to your healthcare provider for clarification or guidance. They are there to support you throughout your treatment journey.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• XELJANZ 1 mg/mL oral solution (Health Professionals SmPC) Available at:
• Tofacitinib (Drugs.com) [Accessed 30 Jun. 2024] (online) Available at:
• tofacitinib tablet (RX) [Accessed 0 Jun. 2024] (online) Available at:
• Tofacitinib (MedlinePlus) [Accessed 17 Jun. 2024] (online) Available at:
• Sandborn WJ, Su C, Sands BE, D’Haens GR, Vermeire S, Schreiber S, Danese S, Feagan BG, Reinisch W, Niezychowski W, Friedman G, Lawendy N, Yu D, Woodworth D, Mukherjee A, Zhang H, Healey P, Panés J; OCTAVE Induction 1, OCTAVE Induction 2, and OCTAVE Sustain Investigators. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2017 May 4;376(18):1723-1736. doi: 10.1056/NEJMoa1606910. [Accessed 8 Jun. 2024] Available at: